This product is for research use only, not for human use. We do not sell to patients.
Size | Price |
---|---|
250mg | Get quote |
500mg | Get quote |
1g | Get quote |
Cat #: V4599 CAS #: 250601-04-8 Purity ≥ 98%
Description: Imiglitazar (also known as TAK559; proposed tradename Pargluva) is a novel, potent and dual human peroxisome proliferator-activated receptor PPARα and PPARγ1 agonist with EC50 values of 67 and 31 nM and with hypoglycemic activity. Muraglitazar had completed phase III clinical trials, however in May, 2006 Bristol-Myers Squibb announced that it had discontinued further development.. Data on muraglitazar isrelatively sparse due to the recent introduction of this agent.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
CAS No. | 250601-04-8 |
---|---|
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.